Cargando…
Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro
The activation of innate immunity via myeloid differentiation factor 88 (MyD88) contributes to ischemia reperfusion (I/R) induced acute kidney injury (AKI) and chronic kidney injury. However, since there have not yet been any effective therapy, the exact pharmacological role of MyD88 in the preventi...
Autores principales: | Zhang, Li-Min, Liu, Jian-Hua, Xue, Cheng-Biao, Li, Ming-Qiang, Xing, Shuai, Zhang, Xue, He, Wen-Tao, Jiang, Feng-Chao, Lu, Xia, Zhou, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887891/ https://www.ncbi.nlm.nih.gov/pubmed/27246399 http://dx.doi.org/10.1038/srep26954 |
Ejemplares similares
-
Ischemia-Reperfusion Lung Injury Is Attenuated in MyD88-Deficient Mice
por: Altemeier, William A., et al.
Publicado: (2013) -
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
por: Luo, Wu, et al.
Publicado: (2022) -
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity
por: Saikh, Kamal U.
Publicado: (2021) -
Vinpocetine alleviate cerebral ischemia/reperfusion injury by down-regulating TLR4/MyD88/NF-κB signaling
por: Wu, Li-Rong, et al.
Publicado: (2017) -
A MyD88 meddles with survival
por: Bashyam, Hema
Publicado: (2007)